Liver transplantation for porphyria: who, when, and how?
about
Acute Hepatic PorphyriaLight-induced depigmentation in planarians models the pathophysiology of acute porphyriasRNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria miceAAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function.Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice.Clinically important features of porphyrin and heme metabolism and the porphyrias.UK experience of liver transplantation for erythropoietic protoporphyria.Liver transplantation in the management of porphyria.Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted LiverLiver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case SeriesThe diagnosis and management of erythropoietic protoporphyriaLiver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria.Porphyrin and heme metabolism and the porphyrias.Liver Involvement in Erythropetic Protoporphyria.Update review of the acute porphyrias.Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria.Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.Acute hepatic porphyrias: Recommendations for evaluation and long-term management.Perioperative Anesthetic Management of Patients Having Liver Transplantation for Uncommon Conditions.Specific Diseases
P2860
Q26781776-578AF5DD-D091-48A7-A931-B93758624C2EQ28829636-9F7E8DEB-E1EF-4185-8B5E-A2A93863C279Q33694417-7D0F78DC-9262-4E4C-8044-EFB8CD44680EQ33730418-19AACACE-5DB4-4A09-A197-A1D5C5760B40Q34556835-3EAF8D0E-FFA3-4BBC-8FF0-EAA3AF2CB51FQ34785744-4C38C297-64C6-446E-A7DE-87748D174251Q35004685-869DBD4F-6712-435E-B22B-917F5414E4F4Q35838589-12E5224B-2420-4FE7-A9A5-150A2F7E8798Q36167051-7F018E9C-9291-4757-87A6-EC8211AA4FD0Q36319508-BD03465C-7215-435B-94C3-EBBF0F1CF014Q36928112-6CCD52A5-6152-4712-9029-8949F2D7C9CCQ37329207-6E27EEE3-8E2D-411B-919B-9BACC927D4EFQ37940992-F3608642-9262-49BC-8022-A68FC74B010CQ38014821-ADFB171E-B556-454E-B700-7C8977010798Q38110514-6DE28BD6-9225-4DD4-8589-0C9338A734DBQ38332323-2C39112F-F4F4-44F3-9753-D54F04A57DEFQ39041104-908E28A2-C761-4D24-BD75-0375A96F10B9Q39484651-611D8A3F-C96D-4B38-87D8-8B9F6A130DCDQ41627013-D2EDDEC0-829F-435E-BD67-E1ED3E7BF28BQ44671694-EA0256C6-18D9-42A8-9B19-B06628A24122Q46425849-B4BF1C38-F589-4933-8115-C135A4596779Q50041762-E241360A-419E-49A8-9B39-F3D80A4DDCD3Q56830079-BEF2188C-AD3B-4DFB-BFC6-7445C5CB6309
P2860
Liver transplantation for porphyria: who, when, and how?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Liver transplantation for porphyria: who, when, and how?
@en
type
label
Liver transplantation for porphyria: who, when, and how?
@en
prefLabel
Liver transplantation for porphyria: who, when, and how?
@en
P2093
P2860
P356
P1476
Liver transplantation for porphyria: who, when, and how?
@en
P2093
Avnish Kumar Seth
Darius Mirza
Elwyn Elias
Michael N Badminton
Scott Russell
P2860
P304
P356
10.1002/LT.21261
P577
2007-09-01T00:00:00Z